𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and efficacy of anti–tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis

✍ Scribed by Alain Meyer; Emmanuel Chatelus; Daniel Wendling; Jean-Marie Berthelot; Emmanuelle Dernis; Eric Houvenagel; Jacques Morel; Olivier Richer; Thierry Schaeverbeke; Jacques-Eric Gottenberg; Jean Sibilia; Club Rhumatisme et Inflammation


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
93 KB
Volume
63
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Antiangiogenic effects of anti–tumor nec
✍ Juan D. Cañete; José L. Pablos; Raimon Sanmartí; Carmen Mallofré; Sara Marsal; J 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

## Abstract ## Objective Neovascularization, with an increased number of synovial vessels with a characteristic morphology, seems to contribute to the progression of psoriatic arthritis (PsA). Accordingly, angiogenesis may be an important therapeutic target in PsA. The aim of this study was to ana

Anti–tumor necrosis factor α therapy and
✍ Sebastian Schneeweiss; Soko Setoguchi; Michael E. Weinblatt; Jeffrey N. Katz; Je 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif

Tolerance and effectiveness of anti–tumo
✍ Genevay, Stéphane ;Finckh, Axel ;Ciurea, Adrian ;Chamot, Anne-Marie ;Kyburz, Die 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

## Abstract ## Objective Limited data have been published on tolerance to and efficacy of classic or biologic disease‐modifying antirheumatic drugs in elderly patients with rheumatoid arthritis (RA). The goal of the present study was to evaluate the tolerance to and effectiveness of anti–tumor nec